In short
This article delves into the use of Metamizole Magnesium in clinical trials, specifically focusing on its potential role in improving pain relief after surgery. The study aims to evaluate the effectiveness and safety of various pain management strategies, including Metamizole Magnesium, in the context of acute postoperative pain. By exploring genetic factors and comparing different medications, researchers hope to optimize pain treatment and minimize adverse reactions for patients undergoing surgical procedures.
At a glance
- Study Type
- Phase IV, low-intervention clinical trial
- Main Objective
- Evaluate the utility of pharmacogenetics in improving acute pain treatment
- Medications Studied
- Metamizole Magnesium, Tramadol, Dexketoprofen
- Metamizole Magnesium Form
- Hard capsules, 575 mg
- Maximum Daily Dose
- 2300 mg
- Administration Route
- Oral
- Target Condition
- Acute postoperative pain
- Participant Criteria
- Adults over 18, scheduled for outpatient third molar extraction
- Genetic Focus
- CYP2D6 and other relevant genes
- Secondary Objectives
- Compare efficacy and safety of medications, investigate genetic influences, evaluate plasma concentration effects
What is Metamizole Magnesium?
Metamizole Magnesium is a medication that belongs to a class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily used for its pain-relieving (analgesic) and fever-reducing (antipyretic) properties. This medication is also known by its brand name Metamizol Normon in some countries.
Uses of Metamizole Magnesium
Metamizole Magnesium is commonly used to treat various types of pain and reduce fever. While the specific clinical trial mentioned doesn't focus solely on Metamizole Magnesium, it provides insights into its potential applications:
- Acute postoperative pain: The medication may be used to manage pain following surgical procedures.
- Fever reduction: It can help lower body temperature in cases of fever.
- General pain relief: It may be prescribed for various types of pain, including headaches, toothaches, or menstrual cramps.
How is Metamizole Magnesium Administered?
According to the clinical trial information, Metamizole Magnesium is administered orally. The specific formulation mentioned is:
- Capsules: Metamizol Normon 575 mg hard capsules
This oral route of administration makes it convenient for patients to take the medication at home or in outpatient settings.
Dosage Information
The clinical trial data provides some insight into the dosing of Metamizole Magnesium:
- Maximum daily dose: 2300 mg (2.3 g)
- Maximum total dose: 6900 mg (6.9 g) over the course of treatment
- Maximum treatment period: 3 days
It's important to note that these dosages are specific to the clinical trial and may not reflect the typical dosing for all patients. Always follow your healthcare provider's instructions regarding dosage and duration of treatment.
Alternative Names
Metamizole Magnesium is known by several other names, which may be useful for patients to recognize:
- Dipyrone Magnesium
- Dipyrone Magnesium Salt
These alternative names refer to the same active substance and may be used interchangeably in different contexts or countries.
Current Research
While the clinical trial mentioned doesn't focus specifically on Metamizole Magnesium, it provides insights into ongoing research in pain management:
- Pharmacogenetics: Researchers are studying how genetic factors influence the effectiveness and safety of pain medications.
- Postoperative pain management: The study aims to improve pain relief after surgery using various medications and genetic testing.
- Comparison with other pain relievers: The trial compares the efficacy and safety of different pain medications, which could provide valuable information for future treatment strategies.
Precautions and Considerations
While Metamizole Magnesium can be an effective pain reliever, patients should be aware of certain precautions:
- Drug interactions: Metamizole may interact with other medications. Inform your healthcare provider about all medications you're taking.
- Pregnancy and breastfeeding: The safety of Metamizole during pregnancy and breastfeeding should be discussed with a healthcare provider.
- Short-term use: The clinical trial suggests a maximum treatment period of 3 days, indicating that Metamizole Magnesium is intended for short-term use.
- Contraindications: Some patients may not be suitable candidates for Metamizole Magnesium. Always discuss your medical history with your healthcare provider.
Remember, while this information provides a general overview of Metamizole Magnesium, it's crucial to consult with a healthcare professional for personalized advice and treatment recommendations.